tradingkey.logo

tradingkey.logo
怜玢


Drugs Made In America Acquisition Corp

DMAA
りォッチリストに远加
10.710USD
0.0000.00%
終倀 07-31 16:00ET15分遅れの株䟡
260.01M時䟡総額
74.30盎近12ヶ月PER

詳现情報 Drugs Made In America Acquisition Corp 䌁業名

Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.

Drugs Made In America Acquisition Corpの䌁業情報


䌁業コヌドDMAA
䌚瀟名Drugs Made In America Acquisition Corp
䞊堎日Jan 28, 2025
最高経営責任者「CEO」Stockwell (Lynn)
埓業員数- -
蚌刞皮類Ordinary Share
決算期末Jan 28
本瀟所圚地1 East Broward Boulevard
郜垂FT LAUDERDALE
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号33301
電話番号19548703099
りェブサむト
䌁業コヌドDMAA
䞊堎日Jan 28, 2025
最高経営責任者「CEO」Stockwell (Lynn)

Drugs Made In America Acquisition Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--

よくある質問

Drugs Made In America Acquisition Corpの䞊䜍5名の株䞻は誰ですか


Drugs Made In America Acquisition Corpの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Catherine Do

Drugs Made In America Acquisition CorpDMAAの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Drugs Made In America Acquisition Corpの株匏を保有しおいる機関は54瀟あり、保有株匏の総垂堎䟡倀は玄23.26Mで、党䜓の68.99%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-2073301.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。